AU1987197A - Gene delivery to mucosal epithelium for immunization or therapeutic purpose - Google Patents

Gene delivery to mucosal epithelium for immunization or therapeutic purpose

Info

Publication number
AU1987197A
AU1987197A AU19871/97A AU1987197A AU1987197A AU 1987197 A AU1987197 A AU 1987197A AU 19871/97 A AU19871/97 A AU 19871/97A AU 1987197 A AU1987197 A AU 1987197A AU 1987197 A AU1987197 A AU 1987197A
Authority
AU
Australia
Prior art keywords
immunization
gene delivery
therapeutic purpose
mucosal epithelium
epithelium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19871/97A
Inventor
Heather Lynn Davis
Gulilat Gebeyehu
Joel Jessee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1987197A publication Critical patent/AU1987197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19871/97A 1997-03-10 1997-03-10 Gene delivery to mucosal epithelium for immunization or therapeutic purpose Abandoned AU1987197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/003421 WO1998040499A1 (en) 1997-03-10 1997-03-10 Gene delivery to mucosal epithelium for immunization or therapeutic purposes

Publications (1)

Publication Number Publication Date
AU1987197A true AU1987197A (en) 1998-09-29

Family

ID=22260472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19871/97A Abandoned AU1987197A (en) 1997-03-10 1997-03-10 Gene delivery to mucosal epithelium for immunization or therapeutic purpose

Country Status (2)

Country Link
AU (1) AU1987197A (en)
WO (1) WO1998040499A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044446A1 (en) * 1996-05-24 1997-11-27 University Of Maryland At Baltimore Dna vaccines for eliciting a mucosal immune response
FR2772047B1 (en) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E GENOMIC SEQUENCE AND POLYPEPTIDES OF CIRCOVIRUS ASSOCIATED WITH PIGLET LOSS DISEASE (MAP), APPLICATIONS TO DIAGNOSIS AND TO PREVENTION AND / OR TREATMENT OF INFECTION
EP1129064B1 (en) * 1998-11-12 2008-01-09 Invitrogen Corporation Transfection reagents
PL210451B1 (en) * 1999-06-10 2012-01-31 Merial Sas DNA vaccines for domestic and sports animals
FR2794648B1 (en) * 1999-06-10 2003-03-07 Merial Sas DNA VACCINES FOR PETS AND SPORTS
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
AUPQ259399A0 (en) * 1999-09-01 1999-09-23 Lustre Investments Pte Ltd Therapeutic agents
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
FR2804028B1 (en) * 2000-01-21 2004-06-04 Merial Sas IMPROVED DNA VACCINES FOR PENSION ANIMALS
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
WO2013086243A2 (en) * 2011-12-07 2013-06-13 Omega Protein Corporation Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease
KR102319843B1 (en) 2013-09-25 2021-10-29 조에티스 서비시즈 엘엘씨 Pcv2b divergent vaccine composition and methods of use
WO2016011203A1 (en) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions with lipid aggregates and methods for efficient delivery of molecules to cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery

Also Published As

Publication number Publication date
WO1998040499A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
AU2946295A (en) Targeted gene delivery system
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU6140598A (en) Multipathway electronically-controlled drug delivery system
AU4787697A (en) Therapeutic gene
AU6558296A (en) Buccal delivery system for therapeutic agents
AU4070097A (en) Mucosal immunogens for novel vaccines
AU2324497A (en) Delivery of nucleic acids by porphyrins
AU7077098A (en) Transdermal delivery system
AUPO066096A0 (en) Oral delivery of peptides
AU6295394A (en) Peptide linkers for improved oligonucleotide delivery
AU3739697A (en) Gene delivery system
AU4139801A (en) Controlled delivery of antigens
AU1987197A (en) Gene delivery to mucosal epithelium for immunization or therapeutic purpose
AUPN741696A0 (en) Delivery of nucleic acids ii
AU7706098A (en) Antigen delivery system
AU3938797A (en) Transdermal delivery of peptides
AU6175398A (en) New delivery system for administering dentin-hypersensitivity-ameliorating compositions
AU4717997A (en) Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
EP1030819A4 (en) Immunogenic conjugated polypeptide for treatment of herpes simplex virus
AU5741699A (en) Low-molecular fragments of hyaluronic acid for the preparation of vaccines
AU3739400A (en) Flint polypeptide analogs
AU5154498A (en) Peptides for gene delivery
AUPQ233799A0 (en) Recombinant sub-unit vaccine
AU4417000A (en) Novel pharmaceutical composition suitable for gene therapy
AU5836700A (en) Peptides for therapeutic use